Becton, Dickinson and Company
NYSE: BDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Thomas E. Polen Jr.
- Employees
- 70,000
- Headquarters
- Franklin Lakes, United States
- IPO year
- 1973
- Market cap
- $52.2B
- Website
- https://www.bd.com
Loading BDX…
Loading profile data…Frequently asked questions about BDX
What does Becton, Dickinson and Company (BDX) do?
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base compr...
Where does BDX trade?
Becton, Dickinson and Company (BDX) trades on the New York Stock Exchange.
What sector is BDX in?
Becton, Dickinson and Company (BDX) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Becton, Dickinson and Company?
Thomas E. Polen Jr. is the chief executive officer of Becton, Dickinson and Company (BDX).
Where is Becton, Dickinson and Company headquartered?
Becton, Dickinson and Company is headquartered in United States.
Does BDX pay a dividend?
Yes — Becton, Dickinson and Company (BDX) paid a trailing twelve-month dividend of USD 3.74 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BDX go public?
Becton, Dickinson and Company (BDX) completed its initial public offering in 1973.